Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Elevated serum prolactin levels as a marker of inflammatory arthritis in psoriasis vulgaris

M. Husakova, J. Lippert, J. Stolfa, L. Sedova, P. Arenberger, Z. Lacinova, K. Pavelka

. 2015 ; 159 (4) : 562-568. [pub] 20150710

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17004321

BACKGROUND AND AIMS: Psoriasis vulgaris (PV) is complicated in up to 40% patients by the inflammatory joint disease psoriatic arthritis (PsA). Neither the aetiology of the arthritis nor specific laboratory markers for its disease activity have been clearly elucidated. Prolactin (PRL) acts as a cytokine with immunomodulatory functions and plays a role in skin and joint biology. The results on PRL however as a marker are unclear. The aim of this study was to confirm whether serum PRL levels reflect systemic complications of PV, like inflammatory joint disease and/or can serve as a marker of disease activity in both cases. METHODS: A total of 70 patients with PV without arthritis and 40 patients suffering from PsA were included. In all patients, we determined skin disease activity according to the PASI index and in PsA, active disease assessed as swollen or tender joints. The control group included 27 age and sex matched healthy individuals. The concentration of PRL in the serum was measured by immunoradiometric assays. RESULTS: The PRL serum levels were significantly increased in PsA patients (299.2±28.29 mIU/L) compared to PV only patients (201.4.2±11.72 mIU/L), P = 0.0003 and healthy individuals (198.2±15.31 mIU/L), P = 0.007. The serum PRL levels in PsA with active disease 336.8±42.50 (mIU/L) were higher than in PV and controls, P < 0.0001 and P = 0.002 respectively. In PV only patients, there was no correlation between PASI and PRL levels. CONCLUSION: Our results showed that PRL serum levels are a marker of active arthritis in PsA and reflects systemic complication rather than local skin activity.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17004321
003      
CZ-PrNML
005      
20170308085105.0
007      
ta
008      
170127s2015 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2015.033 $2 doi
024    7_
$a 10.5507/bp.2015.033 $2 doi
035    __
$a (PubMed)26175050
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Hušáková, Markéta $u Institute of Rheumatology, Prague, Czech Republic $7 xx0143346
245    10
$a Elevated serum prolactin levels as a marker of inflammatory arthritis in psoriasis vulgaris / $c M. Husakova, J. Lippert, J. Stolfa, L. Sedova, P. Arenberger, Z. Lacinova, K. Pavelka
520    9_
$a BACKGROUND AND AIMS: Psoriasis vulgaris (PV) is complicated in up to 40% patients by the inflammatory joint disease psoriatic arthritis (PsA). Neither the aetiology of the arthritis nor specific laboratory markers for its disease activity have been clearly elucidated. Prolactin (PRL) acts as a cytokine with immunomodulatory functions and plays a role in skin and joint biology. The results on PRL however as a marker are unclear. The aim of this study was to confirm whether serum PRL levels reflect systemic complications of PV, like inflammatory joint disease and/or can serve as a marker of disease activity in both cases. METHODS: A total of 70 patients with PV without arthritis and 40 patients suffering from PsA were included. In all patients, we determined skin disease activity according to the PASI index and in PsA, active disease assessed as swollen or tender joints. The control group included 27 age and sex matched healthy individuals. The concentration of PRL in the serum was measured by immunoradiometric assays. RESULTS: The PRL serum levels were significantly increased in PsA patients (299.2±28.29 mIU/L) compared to PV only patients (201.4.2±11.72 mIU/L), P = 0.0003 and healthy individuals (198.2±15.31 mIU/L), P = 0.007. The serum PRL levels in PsA with active disease 336.8±42.50 (mIU/L) were higher than in PV and controls, P < 0.0001 and P = 0.002 respectively. In PV only patients, there was no correlation between PASI and PRL levels. CONCLUSION: Our results showed that PRL serum levels are a marker of active arthritis in PsA and reflects systemic complication rather than local skin activity.
650    _2
$a dospělí $7 D000328
650    _2
$a psoriatická artritida $x diagnóza $7 D015535
650    _2
$a biologické markery $x metabolismus $7 D015415
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a imunoradiometrická analýza $7 D015592
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a prolaktin $x metabolismus $7 D011388
650    _2
$a psoriáza $x diagnóza $7 D011565
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Lippert, Jan, $u Department of Dermatology, Stadt. Klinikum Gorlitz, Gorlitz, Germany $d 1977- $7 xx0121771
700    1_
$a Štolfa, Jiří, $u Institute of Rheumatology, Prague, Czech Republic $d 1944- $7 mzk2007386022
700    1_
$a Šedová, Liliana $u Institute of Rheumatology, Prague, Czech Republic $7 xx0054446
700    1_
$a Arenberger, Petr, $u The Clinic of Dermatology and Venereology, 3rd Faculty of Medicine, Charles University in Prague and Faculty Hospital of Kralovske Vinohrady, Prague $d 1958- $7 nlk19990072992
700    1_
$a Lacinová, Zdeňka $u 3rd Department of Internal Medicine - Department of Endocrinology and Metabolism, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague $7 xx0062138
700    1_
$a Pavelka, Karel, $u Institute of Rheumatology, Prague, Czech Republic $d 1954- $7 jn99240000847
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 159, č. 4 (2015), s. 562-568
856    41
$u http://biomed.papers.upol.cz/ $y domovská stránka časopisu
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20170127 $b ABA008
991    __
$a 20170307133011 $b ABA008
999    __
$a ok $b bmc $g 1192536 $s 964937
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 159 $c 4 $d 562-568 $e 20150710 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20170127

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...